DE60317662D1 - Zusammensetzungen und verfahren zur behandlung von infektionen bei vieh und schweinen - Google Patents

Zusammensetzungen und verfahren zur behandlung von infektionen bei vieh und schweinen

Info

Publication number
DE60317662D1
DE60317662D1 DE60317662T DE60317662T DE60317662D1 DE 60317662 D1 DE60317662 D1 DE 60317662D1 DE 60317662 T DE60317662 T DE 60317662T DE 60317662 T DE60317662 T DE 60317662T DE 60317662 D1 DE60317662 D1 DE 60317662D1
Authority
DE
Germany
Prior art keywords
cattle
pigs
compositions
methods
treating infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60317662T
Other languages
English (en)
Other versions
DE60317662T2 (de
Inventor
Raul E Kohan
Kanwal J Varma
Robert D Simmons
Abu Huq
Keith A Freehauf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of DE60317662D1 publication Critical patent/DE60317662D1/de
Application granted granted Critical
Publication of DE60317662T2 publication Critical patent/DE60317662T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60317662T 2002-05-20 2003-05-19 Zusammensetzungen und verfahren zur behandlung von infektionen bei vieh und schweinen Expired - Lifetime DE60317662T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38201502P 2002-05-20 2002-05-20
US382015P 2002-05-20
PCT/IB2003/002152 WO2003097054A1 (en) 2002-05-20 2003-05-19 Compositions and method for treating infection in cattle and swine

Publications (2)

Publication Number Publication Date
DE60317662D1 true DE60317662D1 (de) 2008-01-03
DE60317662T2 DE60317662T2 (de) 2008-10-30

Family

ID=29550174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60317662T Expired - Lifetime DE60317662T2 (de) 2002-05-20 2003-05-19 Zusammensetzungen und verfahren zur behandlung von infektionen bei vieh und schweinen

Country Status (29)

Country Link
US (3) US6790867B2 (de)
EP (1) EP1505975B1 (de)
JP (2) JP4772324B2 (de)
KR (1) KR101102176B1 (de)
CN (1) CN100563655C (de)
AR (1) AR039826A1 (de)
AU (1) AU2003228042B2 (de)
BR (1) BRPI0311126B1 (de)
CA (1) CA2485491C (de)
CY (1) CY1107176T1 (de)
DE (1) DE60317662T2 (de)
DK (1) DK1505975T3 (de)
EC (1) ECSP045442A (de)
ES (1) ES2295583T3 (de)
HK (1) HK1072547A1 (de)
IL (2) IL165252A0 (de)
MX (1) MXPA04011516A (de)
MY (1) MY135791A (de)
NO (1) NO20045547L (de)
NZ (1) NZ536476A (de)
PE (1) PE20040041A1 (de)
PL (1) PL213975B1 (de)
PT (1) PT1505975E (de)
RU (2) RU2330662C2 (de)
SI (1) SI1505975T1 (de)
TW (1) TWI355266B (de)
UA (1) UA81629C2 (de)
WO (1) WO2003097054A1 (de)
ZA (1) ZA200409296B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US6432203B1 (en) * 1997-03-17 2002-08-13 Applied Komatsu Technology, Inc. Heated and cooled vacuum chamber shield
US20070003508A1 (en) * 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
JP4850390B2 (ja) * 2001-10-19 2012-01-11 アイデックス ラボラトリーズ インコーポレイテッド 薬理学的に活性な化合物の制御送達のための注射用組成物
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
MY146351A (en) 2003-05-29 2012-08-15 Schering Plough Ltd Compositions for treating infection in cattle and swine
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
AU2004287439A1 (en) * 2003-10-29 2005-05-19 Idexx Laboratories, Inc. Salts of pharmacologically active compounds
KR100548948B1 (ko) * 2003-11-24 2006-02-02 주식회사 한동 플로르페니콜의 약제학적 조성물
WO2005091967A2 (en) * 2004-03-03 2005-10-06 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
EP1836162A2 (de) * 2004-09-02 2007-09-26 IDEXX Laboratories Inc Antibakterielle mittel
JP5017122B2 (ja) * 2004-12-21 2012-09-05 インターベツト・インターナシヨナル・ベー・ベー 注射可能な獣医学組成物
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US7518017B2 (en) 2006-02-17 2009-04-14 Idexx Laboratories Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds
WO2008076256A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US8084643B2 (en) * 2006-12-13 2011-12-27 Intervet Inc. Water-soluble prodrugs of florfenicol and its analogs
KR20090090387A (ko) * 2006-12-19 2009-08-25 쉐링-프라우 리미티드 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
BRPI0810601A2 (pt) * 2007-04-27 2014-10-21 Schering Plough Ltd Compostos e métodos para aumento da solubilidade de florfenicol e antibióticos estruturalmente relacionados usando ciclodextrinas
US7550625B2 (en) 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
US8501788B2 (en) 2007-12-14 2013-08-06 Intervet Inc. Process for recovering flunixin from pharmaceutical compositions
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
WO2009143558A1 (en) * 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
CN101461821B (zh) * 2008-07-04 2011-05-18 青岛康地恩药业有限公司 一种用于治疗猪、牛呼吸道疾病的复方口服药物组合物
NZ591235A (en) 2008-07-23 2012-07-27 Ambrx Inc Modified bovine g-csf polypeptides comprising non natural amino acid and their uses treating infections such as mastitis
WO2010014566A2 (en) * 2008-07-30 2010-02-04 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
BRPI1002021A2 (pt) * 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
CN102188422B (zh) * 2011-01-11 2013-11-06 广东大华农动物保健品股份有限公司 一种复方氟苯尼考注射液及其制备方法和应用
EA019956B1 (ru) * 2011-02-24 2014-07-30 Закрытое Акционерное Общество "Нита-Фарм" Фармацевтическая композиция для лечения заболеваний бактериальной и микоплазменной этиологии
UA110436C2 (en) * 2012-03-06 2015-12-25 Zoetis Llc Antibacterial phenol compounds
EP2900641A1 (de) * 2012-09-26 2015-08-05 Zoetis LLC Antibakterielle phenicolstoffe
CN102920701A (zh) * 2012-11-02 2013-02-13 青岛康地恩药业股份有限公司 一种用于治疗猪呼吸道感染疾病的复方氟苯尼考制剂及其制备方法
CN104208062A (zh) * 2013-06-03 2014-12-17 中国农业科学院兰州畜牧与兽药研究所 一种高浓度复方氟苯尼考注射液及其制备方法和应用
CN104095996A (zh) * 2014-08-12 2014-10-15 王忠亮 一种治疗急性脓肿期乳腺炎的药物组合物
CN104188901A (zh) * 2014-08-12 2014-12-10 河南迪冉生物科技有限公司 一种兽用氟苯尼考注射液及其制备方法
CN104370782A (zh) * 2014-11-29 2015-02-25 郑州后羿制药有限公司 一种氟苯尼考的精制方法
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
CN108904442B (zh) * 2018-08-09 2021-04-06 山西瑞象生物药业有限公司 一种氟苯尼考溶液剂及其制备方法
CA3111385A1 (en) * 2018-09-06 2020-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Sustained-release injectable antibiotical formulation
CN110208397B (zh) * 2019-05-17 2022-08-19 河北远征药业有限公司 一种同时测定土霉素氟尼辛注射液中两种主药含量的高效液相色谱法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025325A1 (de) * 1980-07-04 1982-02-04 Merck Patent Gmbh, 6100 Darmstadt Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
HUP0002125A3 (en) 1997-05-06 2001-01-29 Norbrook Lab Ltd Newry Improvements in or relating to long-acting antimicrobials
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
EP1202620A1 (de) * 1999-05-14 2002-05-08 The Regents of the University of California Anti-inflamatorische therapie für inflammatorisch vermittelte injektionen
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
MY146351A (en) * 2003-05-29 2012-08-15 Schering Plough Ltd Compositions for treating infection in cattle and swine

Also Published As

Publication number Publication date
PL213975B1 (pl) 2013-05-31
US20030220302A1 (en) 2003-11-27
MXPA04011516A (es) 2005-02-14
TW200307536A (en) 2003-12-16
EP1505975B1 (de) 2007-11-21
NO20045547L (no) 2004-12-17
NZ536476A (en) 2008-10-31
RU2466726C2 (ru) 2012-11-20
JP2005526849A (ja) 2005-09-08
BRPI0311126B1 (pt) 2016-11-08
UA81629C2 (ru) 2008-01-25
KR101102176B1 (ko) 2012-01-02
ECSP045442A (es) 2005-01-03
AU2003228042B2 (en) 2006-09-21
US6790867B2 (en) 2004-09-14
ZA200409296B (en) 2005-07-27
CY1107176T1 (el) 2012-10-24
JP4772324B2 (ja) 2011-09-14
DK1505975T3 (da) 2008-01-14
RU2330662C2 (ru) 2008-08-10
TWI355266B (en) 2012-01-01
US8044102B2 (en) 2011-10-25
IL165252A0 (en) 2005-12-18
CA2485491C (en) 2012-12-04
CN1652783A (zh) 2005-08-10
KR20050010818A (ko) 2005-01-28
AR039826A1 (es) 2005-03-02
JP2006213731A (ja) 2006-08-17
US20030216447A1 (en) 2003-11-20
AU2003228042A1 (en) 2003-12-02
EP1505975A1 (de) 2005-02-16
SI1505975T1 (sl) 2008-06-30
PE20040041A1 (es) 2004-01-24
BR0311126A (pt) 2005-03-08
ES2295583T3 (es) 2008-04-16
PL374575A1 (en) 2005-10-31
PT1505975E (pt) 2008-01-31
WO2003097054A1 (en) 2003-11-27
CN100563655C (zh) 2009-12-02
HK1072547A1 (en) 2005-09-02
US20050288261A1 (en) 2005-12-29
RU2004137273A (ru) 2005-07-10
MY135791A (en) 2008-06-30
IL165252A (en) 2011-11-30
DE60317662T2 (de) 2008-10-30
RU2008107582A (ru) 2009-09-10
CA2485491A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
DE60317662D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen bei vieh und schweinen
DE60227095D1 (de) Zusammensetzungen und verfahren zur behandlung von abgebundenem gips
DE60141872D1 (de) Formgedächtnislegierung und Verfahren zur Behandlung desselben
DE60231601D1 (de) Einrichtung und verfahren zur behandlung
ATE489955T1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
ATE509615T1 (de) Verfahren und zusammensetzungen zur verhütung und/oder zur behandlung von empfindlicher und/oder trockener haut
DE60003250D1 (de) Reinigungszusammensetzungen und Verfahren zur Reinigung
ATE389417T1 (de) Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
DE69810584T2 (de) Verfahren und Methode zur Behandlung von Abfällen
DE60234449D1 (de) Mittel zur förderung des wachstums von schweinen und verfahren zur förderung des wachstums von schweinen
ATE415163T1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60327856D1 (de) Zusammensetzungen und verfahren zur hautbräunung
ATE463246T1 (de) Formulierung und verfahren zur behandlung von thrombocythämie
ATE328880T1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
ATE359816T1 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
DE602006008588D1 (de) Verfahren zur vorbeugung und/oder behandlung vaginaler infektionen
DE502004005151D1 (de) verfahren zur behandlung von pigmenten in partikulärer form
DE50213931D1 (de) Verfahren und vorrichtung zur behandlung von fehlerverdacht
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
DE602004010548D1 (de) Verfahren zur behandlung von tierhäuten
DE60103939D1 (de) Gehärteter Kautschuk und Verfahren zur Behandlung von gehärtetem Kautschuk
DE602004011275D1 (de) Zusammensetzungen und Verfahren zur Behandlung von Fettleibigkeit
DE60219777D1 (de) Verfahren und vorrichtung zur behandlung von additivhaltigen thermoplastharzzusammensetzungen
ATE500896T1 (de) Verfahren und anlage zur reinigung von getreide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition